Responses
Poster Presentations
Crystal diseases, metabolic bone diseases and bone diseases other than osteoporosis
THU0433 Pharmacodynamic and pharmacokinetic study of verinurad (RDEA3170) in adult male subjects with mild, moderate, and severe renal impairment: a phase 1, open-label study
Compose a Response to This Article
Other responses
No responses have been published for this article.